University of Minnesota. Driven to Discover.
Israelis who got a booster dose had 11.3 times fewer COVID-19 infections.
High-level groups and vaccine companies say there's enough vaccine, but several obstacles block doses from getting to low- and middle-income countries.
FDA says any booster will have to affect deaths and hospitalizations, not just immune response.
Risk factors for being infected include outdoor work exposures, crowded living conditions, and high body mass index.
All global regions saw declines, yet nearly 4 million new cases and more than 62,000 deaths were reported.
The regimen involves 2 different vaccines and was shown safe in adults and children.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2021 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.